Centiva Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Buy
+21,598
New +$2.35M 0.03% 341
2024
Q2
Sell
-14,692
Closed -$303K 2226
2024
Q1
$303K Buy
14,692
+5,859
+66% +$126K 0.01% 1244
2023
Q4
$239K Buy
+8,833
New +$232K 0.01% 1324
2021
Q1
Sell
-1,857
Closed -$239K 1240
2020
Q4
$239K Buy
+1,857
New +$214K 0.01% 725

Other funds holding GH

Centiva Capital's GH Position: Q2 2026 in Review

Centiva Capital opened a new position in Guardant Health (GH) in Q2 2026: 21,598 shares worth $3.24M. The stake represents 0.03% of the portfolio and ranks #341 among its holdings. This is a return to the name: Centiva Capital previously reported a position in GH as recently as Q1 2024.

Centiva Capital first reported a position in GH in Q4 2020 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Centiva Capital held 21,598 shares of Guardant Health worth $3.24M as of Q2 2026.
  • Guardant Health was a new Centiva Capital position in Q2 2026.
  • Guardant Health made up 0.03% of Centiva Capital's portfolio in Q2 2026, its #341 holding.
  • Centiva Capital first reported a position in Guardant Health in Q4 2020 and has held it in 4 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.